Denver Colorado, Nov. 5, 2013 (GLOBE NEWSWIRE) --
November 5, 2013 - FusionPharm, Inc, (OTC: FSPM) ( www.fusionpharminc.com ), the Denver based manufacturer of the PharmPods™ cultivation system ( www.pharmpods.com ) is pleased to announce that it has received it's largest single order from Meadpoint Venture Partners to date, for 14 PharmPod20 High Intensity containers totalling nearly $300,000.00. Shipment of completed units will begin in November and the entire order will be fulfilled by years end.
The order, destined for a Colorado based licensed medical cannabis cultivator, is the first of an expected multi-phase order that will continue into 2014.
"We are very happy with the increase in activity and revenue in Colorado in the second half of 2013 and expect great things in 2014 as we welcome customers from Massachusetts, Washington, Canada and other states to the booming cannabis marketplace " commented company CEO Scott Dittman.
About FusionPharm Inc. (FSPM)
FusionPharm, Inc. (FSPM) ( www.fusionpharminc.com ) was organized to capitalize on opportunities present in the rapidly growing vertical farming and cannabis industries. FusionPharm's primary focus is the development and deployment of the patent pending PharmPods™ advanced hydroponic commercial cultivation systems. PharmPods are constructed from standard ISO steel shipping containers that are repurposed for use in indoor controlled environment agriculture. Modular, stackable, cost competitive and financeable, PharmPods have become the industry leader for professional, commercial scale indoor plant cultivation.
About Meadpoint Venture Partners
Meadpoint Venture Partners is the exclusive licensee and distributor of the FusionPharm High Intensity container cultivation system (better know as PharmPods). Meadpoint is currently conducting a massive North American sales and marketing campaign to show industry professionals the potential of HI containers as an effective and economical medium for the cultivation of cannabis in a high-growth industry.
NOTES ABOUT FORWARD-LOOKING STATEMENTS : Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company's Securities and Exchange Commission reports and filings. Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which they are made.
CONTACT: info@pharmpods.com
